| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,141 |
19,887 |
$3.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,970 |
12,370 |
$2.97M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,100 |
4,291 |
$2.47M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,323 |
7,281 |
$1.08M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,982 |
10,358 |
$919K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,949 |
8,175 |
$801K |
| 99001 |
|
17,193 |
13,403 |
$690K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,067 |
1,756 |
$382K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,908 |
1,634 |
$334K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
740 |
674 |
$322K |
| 71045 |
Radiologic examination, chest; single view |
6,229 |
5,219 |
$268K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,254 |
1,994 |
$260K |
| 97597 |
|
2,864 |
1,337 |
$244K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,412 |
733 |
$240K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,975 |
1,750 |
$199K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,350 |
1,199 |
$197K |
| 71046 |
Radiologic examination, chest; 2 views |
2,763 |
2,545 |
$177K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,975 |
4,276 |
$150K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,583 |
1,353 |
$98K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,608 |
1,314 |
$88K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
544 |
312 |
$85K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
431 |
393 |
$56K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
968 |
838 |
$36K |
| 80050 |
General health panel |
452 |
407 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
12,902 |
10,602 |
$22K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,541 |
5,759 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,540 |
7,003 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,119 |
987 |
$15K |
| 80053 |
Comprehensive metabolic panel |
17,687 |
14,604 |
$14K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
508 |
441 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,358 |
21,130 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,464 |
8,120 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
29 |
26 |
$8K |
| 87631 |
|
687 |
659 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
828 |
656 |
$6K |
| G0378 |
Hospital observation service, per hour |
1,425 |
1,131 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,790 |
1,548 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,753 |
3,206 |
$4K |
| 87400 |
|
1,438 |
1,091 |
$4K |
| 80061 |
Lipid panel |
473 |
430 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,966 |
1,696 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
30 |
25 |
$3K |
| 81001 |
|
8,469 |
7,440 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
45 |
39 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,108 |
1,548 |
$2K |
| 84439 |
|
1,474 |
1,282 |
$2K |
| 87252 |
|
636 |
580 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,478 |
2,259 |
$2K |
| 86900 |
|
285 |
234 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
343 |
325 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,716 |
1,303 |
$1K |
| 83735 |
|
2,958 |
2,342 |
$995.83 |
| 85027 |
|
3,974 |
2,969 |
$982.64 |
| J2704 |
Injection, propofol, 10 mg |
918 |
724 |
$966.44 |
| 0002A |
|
30 |
29 |
$958.36 |
| 81003 |
|
3,166 |
2,790 |
$849.75 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
13 |
$814.68 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
493 |
482 |
$809.89 |
| 87300 |
|
636 |
580 |
$782.95 |
| 82570 |
|
3,895 |
3,320 |
$591.35 |
| G0008 |
Administration of influenza virus vaccine |
29 |
29 |
$584.72 |
| 83880 |
|
2,031 |
1,762 |
$571.58 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,674 |
1,195 |
$541.00 |
| 87420 |
|
181 |
169 |
$520.99 |
| 0001A |
|
32 |
32 |
$493.98 |
| 87077 |
|
1,674 |
1,329 |
$486.33 |
| 84484 |
|
8,111 |
5,179 |
$472.42 |
| 86140 |
|
960 |
835 |
$461.16 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
358 |
339 |
$431.92 |
| 83690 |
|
3,707 |
3,213 |
$390.19 |
| 82565 |
|
87 |
76 |
$377.33 |
| 85610 |
|
2,372 |
1,949 |
$354.73 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,528 |
1,276 |
$342.36 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
267 |
237 |
$313.63 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,107 |
1,829 |
$301.19 |
| 87186 |
|
1,517 |
1,257 |
$264.86 |
| 84100 |
|
1,162 |
1,014 |
$255.73 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
254 |
228 |
$249.87 |
| 83605 |
|
3,864 |
3,063 |
$233.66 |
| 84702 |
|
596 |
537 |
$211.22 |
| 88342 |
|
613 |
559 |
$177.55 |
| 82077 |
|
2,397 |
1,978 |
$149.43 |
| 84481 |
|
13 |
13 |
$137.05 |
| 87070 |
|
1,430 |
1,175 |
$135.25 |
| 82550 |
|
834 |
652 |
$121.30 |
| 84703 |
|
2,407 |
2,094 |
$116.57 |
| 87205 |
|
1,546 |
1,237 |
$78.30 |
| 85730 |
|
437 |
373 |
$71.40 |
| 87088 |
|
240 |
224 |
$62.01 |
| 85652 |
|
275 |
246 |
$53.50 |
| 80076 |
|
265 |
244 |
$42.62 |
| 87075 |
|
496 |
409 |
$33.77 |
| 82140 |
|
14 |
12 |
$27.96 |
| 82803 |
|
36 |
25 |
$25.27 |
| 81025 |
|
763 |
692 |
$25.23 |
| 80179 |
|
998 |
881 |
$17.71 |
| 80143 |
|
1,070 |
926 |
$17.71 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
277 |
255 |
$17.39 |
| 84520 |
|
13 |
12 |
$13.92 |
| 85380 |
|
1,654 |
1,495 |
$12.35 |
| 82553 |
|
74 |
62 |
$11.19 |
| 81002 |
|
364 |
306 |
$9.93 |
| 84145 |
|
75 |
60 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
159 |
76 |
$0.00 |
| 93017 |
|
15 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
95 |
81 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
271 |
247 |
$0.00 |
| 36600 |
|
19 |
12 |
$0.00 |
| 74018 |
|
17 |
15 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
143 |
101 |
$0.00 |
| 86850 |
|
103 |
90 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
261 |
236 |
$0.00 |
| 80320 |
|
80 |
71 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
258 |
197 |
$0.00 |
| 86901 |
|
285 |
234 |
$0.00 |
| 80329 |
|
26 |
18 |
$0.00 |
| 87184 |
|
41 |
25 |
$0.00 |
| 87040 |
|
374 |
176 |
$0.00 |
| 80047 |
|
17 |
15 |
$0.00 |
| 94760 |
|
36 |
24 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
40 |
26 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
107 |
80 |
$0.00 |
| 96376 |
|
118 |
64 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
15 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
12 |
$0.00 |
| 82330 |
|
20 |
12 |
$0.00 |